Literature DB >> 10414506

Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin.

M Devouassoux-Shisheboran1, S A Silver, F A Tavassoli.   

Abstract

Wolffian adnexal tumor (WAT) is a rare neoplasm believed to originate from wolffian remnants on the basis of its location in areas where these remnants are abundant. To study its histogenesis, the immunoprofile of 25 WATs was compared with that of 10 cervical and vaginal mesonephric remnants and 12 rete ovarii. WATs were unilaterally located in the broad ligament (n = 10), mesosalpinx (n = 9), ovarian hilus (n = 5), and pelvis, not otherwise specified (n = 1). They showed varying morphologies with solid (spindle cells), tubular (lined by columnar cells), retiform and multicystic (spaces lined by cuboidal and attenuated cells) patterns. WATs were immunoreactive for pan-cytokeratin (AE1/3, CK1) (100%), CAM 5.2 (100%), cytokeratin 7 (CK7) (88%, focal staining), keratin 903 (17%), epithelial membrane antigen (EMA) (12%), estrogen receptor (28%), progesterone receptor (24%), androgen receptor (78%), inhibin (68%), calretinin (91%), and vimentin (100%). No immunostaining was detected with monoclonal carcinoembryonic antigen and cytokeratin 20. The pattern of staining was nearly identical to that of the rete ovarii and differed somewhat from mesonephric remnants, which were diffusely immunoreactive for CK7, immunopositive for EMA (apical staining), and nonreactive for inhibin. Our findings provide immunohistochemical support for the derivation of WATs from wolffian remnants, in particular from the rete ovarii. Because of immunoreactivity for inhibin and calretinin in a significant number of WATs, our results further show that these immunostains alone do not allow absolute distinction of WATs from sex cord-stromal tumors and adenomatoid tumors, respectively, with which they may be confused.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414506     DOI: 10.1016/s0046-8177(99)90148-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Clear-cell adenoma of the fallopian tube, a rare tumor of the tubal mucosa.

Authors:  Günther Bayer; Johannes Pammer; Reinhard Horvat; Peter Birner
Journal:  Virchows Arch       Date:  2004-05-13       Impact factor: 4.064

2.  [Tumor of the mesosalpinx with unclear differentiation].

Authors:  D Nann; S Gahlen; H G Keul; H J Voigt; F Fend; A Staebler
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

3.  Uterine Paramesonephric Cysts in Sprague-Dawley Rats from National Toxicology Program Studies.

Authors:  Daven N Jackson-Humbles; John Curtis Seely; Ronald A Herbert; David E Malarkey; Barry S McIntyre; Paul M Foster; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2018-04-29       Impact factor: 1.902

4.  Mesonephric adenocarcinoma of the uterine corpus.

Authors:  Haixia Wu; Lin Zhang; Wenfeng Cao; Yuanjing Hu; Yixin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

6.  Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases.

Authors:  Jennifer A Bennett; Lauren L Ritterhouse; Larissa V Furtado; Ricardo R Lastra; Anna Pesci; Jordan M Newell; Eike Burandt; Loes Kooreman; Koen Van de Vijver; Thomas Krausz; Ana Felix; Gian Franco Zannoni; Robert H Young; Esther Oliva
Journal:  Mod Pathol       Date:  2019-10-07       Impact factor: 7.842

7.  Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.

Authors:  Susanna Syriac; Nicole Durie; Joshua Kesterson; Shashrikant Lele; Paulette Mhawech-Fauceglia
Journal:  Int J Gynecol Pathol       Date:  2011-05       Impact factor: 2.762

8.  RARE MALIGNANT FEMALE ADNEXAL TUMOR OF WOLFFIAN ORIGIN (FATWO) WITH MULTIPLE RELAPSES AND CHEMOTHERAPY REGIMENS.

Authors:  A Piciu; C Cainap; D Sur; A Havasi; B Fetica; O Balacescu; A Mester; S Cainap
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

9.  Cystadenofibroma of the rete ovarii: a case report with review of literature.

Authors:  Manisha Ram; Abdel Abdulla; Khalil Razvi; Ivilina Pandeva; Awatif Al-Nafussi
Journal:  Rare Tumors       Date:  2009-07-22

10.  Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.

Authors:  Jelena Mirkovic; Lynette M Sholl; Elizabeth Garcia; Neal Lindeman; Laura MacConaill; Michelle Hirsch; Paola Dal Cin; Melissa Gorman; Justine A Barletta; Marisa R Nucci; W Glenn McCluggage; Brooke E Howitt
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.